BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sałaga M, Mokrowiecka A, Jacenik D, Cygankiewicz AI, Małecka-panas E, Kordek R, Krajewska WM, Sobocinska MK, Kamysz E, Fichna J. Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors. Journal of Crohn's and Colitis 2017;11:988-98. [DOI: 10.1093/ecco-jcc/jjx043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Salaga M, Binienda A, Piscitelli F, Mokrowiecka A, Cygankiewicz AI, Verde R, Malecka-panas E, Kordek R, Krajewska WM, Di Marzo V, Fichna J. Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system. Biochemical Pharmacology 2019;161:37-51. [DOI: 10.1016/j.bcp.2019.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
2 Sochal M, Mosińska P, Fichna J. Diagnostic value of chemerin in lower gastrointestinal diseases—a review. Peptides 2018;108:19-24. [DOI: 10.1016/j.peptides.2018.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Donatello NN, Emer AA, Salm DC, Ludtke DD, Bordignon SASR, Ferreira JK, Salgado ASI, Venzke D, Bretanha LC, Micke GA, Martins DF. Lavandula angustifolia essential oil inhalation reduces mechanical hyperalgesia in a model of inflammatory and neuropathic pain: The involvement of opioid and cannabinoid receptors. Journal of Neuroimmunology 2020;340:577145. [DOI: 10.1016/j.jneuroim.2020.577145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mizerska-Kowalska M, Kreczko-Kurzawa J, Zdzisińska B, Czerwonka A, Sławińska-Brych A, Maćkiewicz Z, Nidzworski D, Kandefer-Szerszeń M. Neutral endopeptidase (NEP) inhibitors - thiorphan, sialorphin, and its derivatives exert anti-proliferative activity towards colorectal cancer cells in vitro. Chem Biol Interact 2019;307:105-15. [PMID: 31054283 DOI: 10.1016/j.cbi.2019.04.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Sobocińska M, Giełdoń A, Fichna J, Kamysz E. Alanine scan of sialorphin and its hybrids with opiorphin: synthesis, molecular modelling and effect on enkephalins degradation. Amino Acids 2018;50:1083-8. [PMID: 29752565 DOI: 10.1007/s00726-018-2585-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Melo FJ, Pinto-Lopes P, Estevinho MM, Magro F. The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.Inflamm Bowel Dis. 2021;27:1153-1165. [PMID: 33295607 DOI: 10.1093/ibd/izaa324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sobocińska M, Giełdoń A, Fichna J, Kamysz E. 1-Substituted sialorphin analogues-synthesis, molecular modelling and in vitro effect on enkephalins degradation by NEP. Amino Acids 2019;51:1201-7. [PMID: 31302778 DOI: 10.1007/s00726-019-02760-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Sobocińska M, Salaga M, Fichna J, Kamysz E. Anti-Inflammatory Effect of Homo- and Heterodimers of Natural Enkephalinase Inhibitors in Experimental Colitis in Mice. Molecules 2020;25:E5820. [PMID: 33321720 DOI: 10.3390/molecules25245820] [Reference Citation Analysis]
9 Alizadeh R, Aghsaie Fard Z. Renal impairment and analgesia: From effectiveness to adverse effects. J Cell Physiol 2019;234:17205-11. [PMID: 30916404 DOI: 10.1002/jcp.28506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Dalefield ML, Scouller B, Bibi R, Kivell BM. The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies. Front Pharmacol 2022;13:837671. [DOI: 10.3389/fphar.2022.837671] [Reference Citation Analysis]
11 Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol 2020;11:e00120. [PMID: 31899693 DOI: 10.14309/ctg.0000000000000120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
12 Bodnar RJ. Endogenous opiates and behavior: 2017. Peptides 2020;124:170223. [DOI: 10.1016/j.peptides.2019.170223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
13 Lu C, Amin MA, Fox DA. CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders. J Immunol 2020;204:3-11. [PMID: 31848300 DOI: 10.4049/jimmunol.1900868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]